BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8984338)

  • 21. Rapamycin-induced proteinuria following allogeneic hematopoietic stem cell transplantation.
    Hochegger K; Wurz E; Nachbaur D; Rosenkranz AR; Clausen J
    Bone Marrow Transplant; 2009 Jul; 44(1):63-5. PubMed ID: 19151795
    [No Abstract]   [Full Text] [Related]  

  • 22. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts.
    Peters C; Schrauder A; Schrappe M; von Stackelberg A; Stary J; Yaniv I; Gadner H; Klingebiel T;
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S9-11. PubMed ID: 15812540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling.
    Ikegame K; Tanji Y; Kitai N; Tamaki H; Kawakami M; Fujioka T; Oka Y; Maruya E; Saji H; Sugiyama H; Ogawa H
    Bone Marrow Transplant; 2003 Mar; 31(6):507-10. PubMed ID: 12665848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia.
    Singhal S; Powles R; Henslee-Downey PJ; Chiang KY; Treleaven J; Godder K; Kulkarni S; van Rhee F; Sirohi B; Pinkerton CR; Meller S; Mehta J
    Bone Marrow Transplant; 2002 Feb; 29(4):291-5. PubMed ID: 11896425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G; Foncuberta MC; Aversa L; Drelichman G; Freigeiro D; Burgos R; Irrazabal C; Gonzalez G; Dictar M; Niborski R; Kohan A; Sanchez Avalos JC
    Medicina (B Aires); 2000; 60(2):179-87. PubMed ID: 10962806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells.
    Fang B; Song YP; Liao LM; Han Q; Zhao RC
    Bone Marrow Transplant; 2006 Sep; 38(5):389-90. PubMed ID: 16878145
    [No Abstract]   [Full Text] [Related]  

  • 28. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
    Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results.
    Rubinstein P; Stevens CE
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):565-84. PubMed ID: 11102277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous blood pleurodesis for pneumothorax complicating graft-versus-host disease-related bronchiolitis obliterans.
    Chadwick C; Marven SM; Vora AJ
    Bone Marrow Transplant; 2004 Feb; 33(4):451-3. PubMed ID: 14716352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature.
    Yoshihara T; Morimoto A; Kuroda H; Imamura T; Ishida H; Tsunamoto K; Naya M; Hibi S; Todo S; Imashuku S
    Bone Marrow Transplant; 2006 Jan; 37(1):25-31. PubMed ID: 16247416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation.
    Sirvent N; Reviron D; de Lamballerie X; Michel G
    Bone Marrow Transplant; 2000 Jan; 25(1):120-1. PubMed ID: 10654028
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
    Eapen M; Rubinstein P; Zhang MJ; Camitta BM; Stevens C; Cairo MS; Davies SM; Doyle JJ; Kurtzberg J; Pulsipher MA; Ortega JJ; Scaradavou A; Horowitz MM; Wagner JE
    J Clin Oncol; 2006 Jan; 24(1):145-51. PubMed ID: 16382124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease.
    Adamkiewicz TV; Mehta PS; Boyer MW; Kedar A; Olson TA; Olson E; Chiang KY; Maurer D; Mogul MJ; Wingard JR; Yeager AM
    Bone Marrow Transplant; 2004 Sep; 34(5):405-11. PubMed ID: 15247929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference.
    Locatelli F; Pende D; Maccario R; Mingari MC; Moretta A; Moretta L
    Clin Immunol; 2009 Nov; 133(2):171-8. PubMed ID: 19481979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
    J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alloreactivity and umbilical cord blood transplantation].
    Gallardo D; Rojas I; Domínguez E; Madrigal A
    Sangre (Barc); 1997 Apr; 42(2):113-6. PubMed ID: 9297258
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens.
    Gassas A; Sung L; Saunders EF; Doyle JJ
    Bone Marrow Transplant; 2006 Dec; 38(11):739-43. PubMed ID: 17013424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.